Pu X P, Iwamoto A, Nishimura H, Nagasawa S
Department of Hygienic Chemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Biochim Biophys Acta. 1994 Oct 19;1208(2):338-43. doi: 10.1016/0167-4838(94)90122-8.
A 120 kDa plasma protein, which is susceptible to plasma kallikrein, was purified from human plasma by polyethylene glycol fractionation followed by ion exchange chromatography using Q-Sepharose, S-Sepharose, and hydroxyapatite and gel filtration on Sephacryl S-200. The 120 kDa protein, termed PK-120 in this paper, was a single polypeptide chain containing about 20% sugar by weight and its concentration in plasma was estimated to be 80 micrograms/ml by ELISA. At least three fragments, 100, 70, and 35 kDa, were produced from PK-120 by plasma kallikrein. The N-terminal sequence and Western blot demonstrated that PK-120 was first cleaved to yield the 100 and 35 kDa fragments, then the 100 kDa fragment was cleaved into the 70 kDa fragment. N-Terminal sequence analyses of PK-120 and its fragments demonstrated that it is a novel plasma protein, distinct from high molecular weight kininogen, a natural substrate for plasma kallikrein.
一种分子量为120 kDa、对血浆激肽释放酶敏感的血浆蛋白,通过聚乙二醇分级分离从人血浆中纯化出来,随后依次使用Q-Sepharose、S-Sepharose和羟基磷灰石进行离子交换色谱,并在Sephacryl S-200上进行凝胶过滤。本文中称为PK-120的120 kDa蛋白是一条单多肽链,按重量计含糖约20%,通过酶联免疫吸附测定法(ELISA)估计其在血浆中的浓度为80微克/毫升。血浆激肽释放酶从PK-120产生至少三个片段,分别为100 kDa、70 kDa和35 kDa。N端序列和蛋白质印迹表明,PK-120首先被切割产生100 kDa和35 kDa片段,然后100 kDa片段被切割成70 kDa片段。PK-120及其片段的N端序列分析表明,它是一种新型血浆蛋白,不同于血浆激肽释放酶的天然底物高分子量激肽原。